Page last updated: 2024-08-17

n-vinyl-2-pyrrolidinone and Neonatal Sepsis

n-vinyl-2-pyrrolidinone has been researched along with Neonatal Sepsis in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Courtenay, AJ; Donnelly, RF; González-Vázquez, P; Jarrahian, C; Larrañeta, E; McCarthy, H; McCrudden, MTC; Quintanar-Solares, M; Rein-Weston, A; Zehrung, D1

Other Studies

1 other study(ies) available for n-vinyl-2-pyrrolidinone and Neonatal Sepsis

ArticleYear
Transdermal delivery of gentamicin using dissolving microneedle arrays for potential treatment of neonatal sepsis.
    Journal of controlled release : official journal of the Controlled Release Society, 2017, Nov-10, Volume: 265

    Topics: Administration, Cutaneous; Animals; Animals, Newborn; Anti-Bacterial Agents; Drug Delivery Systems; Excipients; Female; Gentamicins; Humans; Kinetics; Mechanical Phenomena; Microinjections; Needles; Neonatal Sepsis; Permeability; Povidone; Rats, Sprague-Dawley; Skin; Solubility

2017